Kidney/Renal fibrosis, defined as an aberrant wound healing process in response to chronic injury, is characterized by the progressive and persistent accumulation of extracellular matrix components (ECM) in the kidney, ultimately leading to renal failure.

The global Kidney & Renal Fibrosis Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Kidney & Renal Fibrosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney & Renal Fibrosis Treatment.

Report Scope

The Kidney & Renal Fibrosis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Kidney & Renal Fibrosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Kidney & Renal Fibrosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Kidney & Renal Fibrosis Treatment Market Report

Report Metric	Details
Report Name	Kidney & Renal Fibrosis Treatment Market
CAGR	5%
Segment by Type	Angiotensin II Receptor Blockers (ARBs) Angiotensin Converting Enzyme (ACE) Inhibitors Pirfenidone Renin Inhibitors Vasopeptidase Inhibitors
Segment by Application	Commercial/Private Hospitals Public Health Hospitals Clinics Home Treatment
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Galectin Therapeutics, Merck & Co., F. Hoffman-La Roche Ltd., Pfizer Inc., InterMune Inc., ProMetic Life-Sciences Inc., La Jolla Pharmaceutical Company, Genzyme Corporation, BioLine Rx Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney & Renal Fibrosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Kidney & Renal Fibrosis Treatment Market report?

Ans: The main players in the Kidney & Renal Fibrosis Treatment Market are Galectin Therapeutics, Merck & Co., F. Hoffman-La Roche Ltd., Pfizer Inc., InterMune Inc., ProMetic Life-Sciences Inc., La Jolla Pharmaceutical Company, Genzyme Corporation, BioLine Rx Ltd

What are the Application segmentation covered in the Kidney & Renal Fibrosis Treatment Market report?

Ans: The Applications covered in the Kidney & Renal Fibrosis Treatment Market report are Commercial/Private Hospitals, Public Health Hospitals, Clinics, Home Treatment

What are the Type segmentation covered in the Kidney & Renal Fibrosis Treatment Market report?

Ans: The Types covered in the Kidney & Renal Fibrosis Treatment Market report are Angiotensin II Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Pirfenidone, Renin Inhibitors, Vasopeptidase Inhibitors

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Angiotensin II Receptor Blockers (ARBs)

1.2.3 Angiotensin Converting Enzyme (ACE) Inhibitors

1.2.4 Pirfenidone

1.2.5 Renin Inhibitors

1.2.6 Vasopeptidase Inhibitors

1.3 Market by Application

1.3.1 Global Kidney & Renal Fibrosis Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Commercial/Private Hospitals

1.3.3 Public Health Hospitals

1.3.4 Clinics

1.3.5 Home Treatment

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Kidney & Renal Fibrosis Treatment Market Perspective (2019-2030)

2.2 Kidney & Renal Fibrosis Treatment Growth Trends by Region

2.2.1 Global Kidney & Renal Fibrosis Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Kidney & Renal Fibrosis Treatment Historic Market Size by Region (2019-2024)

2.2.3 Kidney & Renal Fibrosis Treatment Forecasted Market Size by Region (2025-2030)

2.3 Kidney & Renal Fibrosis Treatment Market Dynamics

2.3.1 Kidney & Renal Fibrosis Treatment Industry Trends

2.3.2 Kidney & Renal Fibrosis Treatment Market Drivers

2.3.3 Kidney & Renal Fibrosis Treatment Market Challenges

2.3.4 Kidney & Renal Fibrosis Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Kidney & Renal Fibrosis Treatment Players by Revenue

3.1.1 Global Top Kidney & Renal Fibrosis Treatment Players by Revenue (2019-2024)

3.1.2 Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Kidney & Renal Fibrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Kidney & Renal Fibrosis Treatment Revenue

3.4 Global Kidney & Renal Fibrosis Treatment Market Concentration Ratio

3.4.1 Global Kidney & Renal Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Kidney & Renal Fibrosis Treatment Revenue in 2023

3.5 Kidney & Renal Fibrosis Treatment Key Players Head office and Area Served

3.6 Key Players Kidney & Renal Fibrosis Treatment Product Solution and Service

3.7 Date of Enter into Kidney & Renal Fibrosis Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Kidney & Renal Fibrosis Treatment Breakdown Data by Type

4.1 Global Kidney & Renal Fibrosis Treatment Historic Market Size by Type (2019-2024)

4.2 Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Type (2025-2030)

5 Kidney & Renal Fibrosis Treatment Breakdown Data by Application

5.1 Global Kidney & Renal Fibrosis Treatment Historic Market Size by Application (2019-2024)

5.2 Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Kidney & Renal Fibrosis Treatment Market Size (2019-2030)

6.2 North America Kidney & Renal Fibrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Kidney & Renal Fibrosis Treatment Market Size by Country (2019-2024)

6.4 North America Kidney & Renal Fibrosis Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Kidney & Renal Fibrosis Treatment Market Size (2019-2030)

7.2 Europe Kidney & Renal Fibrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Kidney & Renal Fibrosis Treatment Market Size by Country (2019-2024)

7.4 Europe Kidney & Renal Fibrosis Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size (2019-2030)

8.2 Asia-Pacific Kidney & Renal Fibrosis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Kidney & Renal Fibrosis Treatment Market Size (2019-2030)

9.2 Latin America Kidney & Renal Fibrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Kidney & Renal Fibrosis Treatment Market Size by Country (2019-2024)

9.4 Latin America Kidney & Renal Fibrosis Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size (2019-2030)

10.2 Middle East & Africa Kidney & Renal Fibrosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Galectin Therapeutics

11.1.1 Galectin Therapeutics Company Detail

11.1.2 Galectin Therapeutics Business Overview

11.1.3 Galectin Therapeutics Kidney & Renal Fibrosis Treatment Introduction

11.1.4 Galectin Therapeutics Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.1.5 Galectin Therapeutics Recent Development

11.2 Merck & Co.

11.2.1 Merck & Co. Company Detail

11.2.2 Merck & Co. Business Overview

11.2.3 Merck & Co. Kidney & Renal Fibrosis Treatment Introduction

11.2.4 Merck & Co. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.2.5 Merck & Co. Recent Development

11.3 F. Hoffman-La Roche Ltd.

11.3.1 F. Hoffman-La Roche Ltd. Company Detail

11.3.2 F. Hoffman-La Roche Ltd. Business Overview

11.3.3 F. Hoffman-La Roche Ltd. Kidney & Renal Fibrosis Treatment Introduction

11.3.4 F. Hoffman-La Roche Ltd. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.3.5 F. Hoffman-La Roche Ltd. Recent Development

11.4 Pfizer Inc.

11.4.1 Pfizer Inc. Company Detail

11.4.2 Pfizer Inc. Business Overview

11.4.3 Pfizer Inc. Kidney & Renal Fibrosis Treatment Introduction

11.4.4 Pfizer Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.4.5 Pfizer Inc. Recent Development

11.5 InterMune Inc.

11.5.1 InterMune Inc. Company Detail

11.5.2 InterMune Inc. Business Overview

11.5.3 InterMune Inc. Kidney & Renal Fibrosis Treatment Introduction

11.5.4 InterMune Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.5.5 InterMune Inc. Recent Development

11.6 ProMetic Life-Sciences Inc.

11.6.1 ProMetic Life-Sciences Inc. Company Detail

11.6.2 ProMetic Life-Sciences Inc. Business Overview

11.6.3 ProMetic Life-Sciences Inc. Kidney & Renal Fibrosis Treatment Introduction

11.6.4 ProMetic Life-Sciences Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.6.5 ProMetic Life-Sciences Inc. Recent Development

11.7 La Jolla Pharmaceutical Company

11.7.1 La Jolla Pharmaceutical Company Company Detail

11.7.2 La Jolla Pharmaceutical Company Business Overview

11.7.3 La Jolla Pharmaceutical Company Kidney & Renal Fibrosis Treatment Introduction

11.7.4 La Jolla Pharmaceutical Company Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.7.5 La Jolla Pharmaceutical Company Recent Development

11.8 Genzyme Corporation

11.8.1 Genzyme Corporation Company Detail

11.8.2 Genzyme Corporation Business Overview

11.8.3 Genzyme Corporation Kidney & Renal Fibrosis Treatment Introduction

11.8.4 Genzyme Corporation Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.8.5 Genzyme Corporation Recent Development

11.9 BioLine Rx Ltd

11.9.1 BioLine Rx Ltd Company Detail

11.9.2 BioLine Rx Ltd Business Overview

11.9.3 BioLine Rx Ltd Kidney & Renal Fibrosis Treatment Introduction

11.9.4 BioLine Rx Ltd Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024)

11.9.5 BioLine Rx Ltd Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Galectin Therapeutics

Merck

F. Hoffman-La Roche Ltd.

Pfizer Inc

InterMune

ProMetic Life Sciences Inc

La Jolla Pharmaceutical Company

Genzyme Corporation

BioLine Rx Ltd

List of Tables

Table 1. Global Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Angiotensin II Receptor Blockers (ARBs)

Table 3. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors

Table 4. Key Players of Pirfenidone

Table 5. Key Players of Renin Inhibitors

Table 6. Key Players of Vasopeptidase Inhibitors

Table 7. Global Kidney & Renal Fibrosis Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Kidney & Renal Fibrosis Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Kidney & Renal Fibrosis Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Kidney & Renal Fibrosis Treatment Market Share by Region (2019-2024)

Table 11. Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Kidney & Renal Fibrosis Treatment Market Share by Region (2025-2030)

Table 13. Kidney & Renal Fibrosis Treatment Market Trends

Table 14. Kidney & Renal Fibrosis Treatment Market Drivers

Table 15. Kidney & Renal Fibrosis Treatment Market Challenges

Table 16. Kidney & Renal Fibrosis Treatment Market Restraints

Table 17. Global Kidney & Renal Fibrosis Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Kidney & Renal Fibrosis Treatment Market Share by Players (2019-2024)

Table 19. Global Top Kidney & Renal Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney & Renal Fibrosis Treatment as of 2023)

Table 20. Ranking of Global Top Kidney & Renal Fibrosis Treatment Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Kidney & Renal Fibrosis Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Kidney & Renal Fibrosis Treatment Product Solution and Service

Table 24. Date of Enter into Kidney & Renal Fibrosis Treatment Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Kidney & Renal Fibrosis Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Type (2019-2024)

Table 28. Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Type (2025-2030)

Table 30. Global Kidney & Renal Fibrosis Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Application (2019-2024)

Table 32. Global Kidney & Renal Fibrosis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Kidney & Renal Fibrosis Treatment Revenue Market Share by Application (2025-2030)

Table 34. North America Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Kidney & Renal Fibrosis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Kidney & Renal Fibrosis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Kidney & Renal Fibrosis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Kidney & Renal Fibrosis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Kidney & Renal Fibrosis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Kidney & Renal Fibrosis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 49. Galectin Therapeutics Company Detail

Table 50. Galectin Therapeutics Business Overview

Table 51. Galectin Therapeutics Kidney & Renal Fibrosis Treatment Product

Table 52. Galectin Therapeutics Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 53. Galectin Therapeutics Recent Development

Table 54. Merck & Co. Company Detail

Table 55. Merck & Co. Business Overview

Table 56. Merck & Co. Kidney & Renal Fibrosis Treatment Product

Table 57. Merck & Co. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 58. Merck & Co. Recent Development

Table 59. F. Hoffman-La Roche Ltd. Company Detail

Table 60. F. Hoffman-La Roche Ltd. Business Overview

Table 61. F. Hoffman-La Roche Ltd. Kidney & Renal Fibrosis Treatment Product

Table 62. F. Hoffman-La Roche Ltd. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 63. F. Hoffman-La Roche Ltd. Recent Development

Table 64. Pfizer Inc. Company Detail

Table 65. Pfizer Inc. Business Overview

Table 66. Pfizer Inc. Kidney & Renal Fibrosis Treatment Product

Table 67. Pfizer Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 68. Pfizer Inc. Recent Development

Table 69. InterMune Inc. Company Detail

Table 70. InterMune Inc. Business Overview

Table 71. InterMune Inc. Kidney & Renal Fibrosis Treatment Product

Table 72. InterMune Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 73. InterMune Inc. Recent Development

Table 74. ProMetic Life-Sciences Inc. Company Detail

Table 75. ProMetic Life-Sciences Inc. Business Overview

Table 76. ProMetic Life-Sciences Inc. Kidney & Renal Fibrosis Treatment Product

Table 77. ProMetic Life-Sciences Inc. Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 78. ProMetic Life-Sciences Inc. Recent Development

Table 79. La Jolla Pharmaceutical Company Company Detail

Table 80. La Jolla Pharmaceutical Company Business Overview

Table 81. La Jolla Pharmaceutical Company Kidney & Renal Fibrosis Treatment Product

Table 82. La Jolla Pharmaceutical Company Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 83. La Jolla Pharmaceutical Company Recent Development

Table 84. Genzyme Corporation Company Detail

Table 85. Genzyme Corporation Business Overview

Table 86. Genzyme Corporation Kidney & Renal Fibrosis Treatment Product

Table 87. Genzyme Corporation Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 88. Genzyme Corporation Recent Development

Table 89. BioLine Rx Ltd Company Detail

Table 90. BioLine Rx Ltd Business Overview

Table 91. BioLine Rx Ltd Kidney & Renal Fibrosis Treatment Product

Table 92. BioLine Rx Ltd Revenue in Kidney & Renal Fibrosis Treatment Business (2019-2024) & (US$ Million)

Table 93. BioLine Rx Ltd Recent Development

Table 94. Research Programs/Design for This Report

Table 95. Key Data Information from Secondary Sources

Table 96. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Kidney & Renal Fibrosis Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Kidney & Renal Fibrosis Treatment Market Share by Type: 2023 VS 2030

Figure 3. Angiotensin II Receptor Blockers (ARBs) Features

Figure 4. Angiotensin Converting Enzyme (ACE) Inhibitors Features

Figure 5. Pirfenidone Features

Figure 6. Renin Inhibitors Features

Figure 7. Vasopeptidase Inhibitors Features

Figure 8. Global Kidney & Renal Fibrosis Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Kidney & Renal Fibrosis Treatment Market Share by Application: 2023 VS 2030

Figure 10. Commercial/Private Hospitals Case Studies

Figure 11. Public Health Hospitals Case Studies

Figure 12. Clinics Case Studies

Figure 13. Home Treatment Case Studies

Figure 14. Kidney & Renal Fibrosis Treatment Report Years Considered

Figure 15. Global Kidney & Renal Fibrosis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Kidney & Renal Fibrosis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Kidney & Renal Fibrosis Treatment Market Share by Region: 2023 VS 2030

Figure 18. Global Kidney & Renal Fibrosis Treatment Market Share by Players in 2023

Figure 19. Global Top Kidney & Renal Fibrosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney & Renal Fibrosis Treatment as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Kidney & Renal Fibrosis Treatment Revenue in 2023

Figure 21. North America Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Kidney & Renal Fibrosis Treatment Market Share by Country (2019-2030)

Figure 23. United States Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Kidney & Renal Fibrosis Treatment Market Share by Country (2019-2030)

Figure 27. Germany Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Kidney & Renal Fibrosis Treatment Market Share by Region (2019-2030)

Figure 35. China Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Kidney & Renal Fibrosis Treatment Market Share by Country (2019-2030)

Figure 43. Mexico Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Kidney & Renal Fibrosis Treatment Market Share by Country (2019-2030)

Figure 47. Turkey Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Kidney & Renal Fibrosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Galectin Therapeutics Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 50. Merck & Co. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 51. F. Hoffman-La Roche Ltd. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 52. Pfizer Inc. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 53. InterMune Inc. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 54. ProMetic Life-Sciences Inc. Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 55. La Jolla Pharmaceutical Company Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 56. Genzyme Corporation Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 57. BioLine Rx Ltd Revenue Growth Rate in Kidney & Renal Fibrosis Treatment Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-35Y14435

Tue Nov 12 00:00:00 UTC 2024

Add to Cart

Self-adhesive Pain Relief Patches - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-19Y14090

Mon Nov 11 00:00:00 UTC 2024

Add to Cart

Stereotactic Radiosurgery (SRS) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-14C14333

Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Vascular Surgery Magnifier - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-23I17442

Fri Nov 08 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Kidney & Renal Fibrosis Treatment Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-10O6067

Global Kidney & Renal Fibrosis Treatment Market Research Report 2024

FEATURED COMPANIES

Kidney & Renal Fibrosis Treatment Market Size

Kidney & Renal Fibrosis Treatment Market

Report Scope

Scope of Kidney & Renal Fibrosis Treatment Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Kidney & Renal Fibrosis Treatment Market report?

What are the Application segmentation covered in the Kidney & Renal Fibrosis Treatment Market report?

What are the Type segmentation covered in the Kidney & Renal Fibrosis Treatment Market report?

FEATURED COMPANIES

RELATED REPORTS